Table 2.
CpG sites that correlate with both exon expression and survival outcome
| CpG | Gene | Cancer | P-value | FDR |
|---|---|---|---|---|
| cg20351640 | CD302 | brain | 1.70E-08 | 0.000138852 |
| cg03903831 | RP11-307N16.6 | brain | 3.51E-08 | 0.000181116 |
| cg27048140 | ATP5J2-PTCD1 | brain | 8.93E-08 | 0.000289902 |
| cg19857457 | RPL17-C18orf32 | breast | 1.09E-08 | 0.000337161 |
| cg03903831 | SPATA13 | brain | 1.88E-07 | 0.000432463 |
| cg05032848 | RFFL | brain | 2.45E-07 | 0.000497251 |
| cg20477147 | NPEPL1 | brain | 3.95E-07 | 0.000600647 |
| cg24859623 | CD302 | brain | 3.95E-07 | 0.000600647 |
| cg09088496 | RP11-307N16.6 | brain | 3.86E-07 | 0.000600647 |
| cg04735129 | CD302 | brain | 4.81E-07 | 0.000657035 |
| cg08347373 | CD302 | brain | 5.69E-07 | 0.000711062 |
| cg08278937 | SERINC4 | brain | 7.10E-07 | 0.000783884 |
| cg16992627 | TNXB | brain | 8.01E-07 | 0.000830607 |
| cg21870038 | RFFL | brain | 8.07E-07 | 0.000830823 |
| cg13586610 | TNXB | brain | 1.07E-06 | 0.000969694 |
| cg22158248 | ALDH2 | brain | 1.23E-06 | 0.001040217 |
| cg13799005 | RP11-644F5.10 | brain | 1.25E-06 | 0.001049216 |
| cg09088496 | SPATA13 | brain | 1.97E-06 | 0.00123508 |
| cg06017559 | RP11-161M6.2 | brain | 2.34E-06 | 0.001332273 |
| cg07204711 | CDK3 | brain | 2.32E-06 | 0.001332273 |
*P-value and FDR are for log-rank test of CpG association with survival